CORPAY INC (CPAY)

US2199481068 - Common Stock

375.46  +6.22 (+1.68%)

After market: 375.46 0 (0%)

Fundamental Rating

5

Overall CPAY gets a fundamental rating of 5 out of 10. We evaluated CPAY against 100 industry peers in the Financial Services industry. While CPAY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CPAY has a decent growth rate and is not valued too expensively.



7

1. Profitability

1.1 Basic Checks

In the past year CPAY was profitable.
CPAY had a positive operating cash flow in the past year.
CPAY had positive earnings in each of the past 5 years.
In the past 5 years CPAY always reported a positive cash flow from operatings.

1.2 Ratios

CPAY has a better Return On Assets (5.75%) than 82.00% of its industry peers.
CPAY has a better Return On Equity (32.83%) than 94.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.10%, CPAY belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
CPAY had an Average Return On Invested Capital over the past 3 years of 12.39%. This is above the industry average of 7.54%.
Industry RankSector Rank
ROA 5.75%
ROE 32.83%
ROIC 12.1%
ROA(3y)6.46%
ROA(5y)6.6%
ROE(3y)32.25%
ROE(5y)28.37%
ROIC(3y)12.39%
ROIC(5y)11.79%

1.3 Margins

With a decent Profit Margin value of 26.14%, CPAY is doing good in the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CPAY has declined.
Looking at the Operating Margin, with a value of 44.43%, CPAY belongs to the top of the industry, outperforming 87.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CPAY has remained more or less at the same level.
CPAY has a better Gross Margin (78.29%) than 84.00% of its industry peers.
CPAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 44.43%
PM (TTM) 26.14%
GM 78.29%
OM growth 3Y2.7%
OM growth 5Y-0.33%
PM growth 3Y-3.94%
PM growth 5Y-4.76%
GM growth 3YN/A
GM growth 5Y-4.8%

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CPAY is still creating some value.
The number of shares outstanding for CPAY has been reduced compared to 1 year ago.
CPAY has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CPAY has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.34 indicates that CPAY is not a great score, but indicates only limited risk for bankruptcy at the moment.
CPAY's Altman-Z score of 2.34 is fine compared to the rest of the industry. CPAY outperforms 79.00% of its industry peers.
The Debt to FCF ratio of CPAY is 3.34, which is a good value as it means it would take CPAY, 3.34 years of fcf income to pay off all of its debts.
CPAY's Debt to FCF ratio of 3.34 is fine compared to the rest of the industry. CPAY outperforms 70.00% of its industry peers.
A Debt/Equity ratio of 2.13 is on the high side and indicates that CPAY has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.13, CPAY is doing worse than 67.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF 3.34
Altman-Z 2.34
ROIC/WACC1.48
WACC8.17%

2.3 Liquidity

A Current Ratio of 1.05 indicates that CPAY should not have too much problems paying its short term obligations.
CPAY's Current ratio of 1.05 is in line compared to the rest of the industry. CPAY outperforms 47.00% of its industry peers.
CPAY has a Quick Ratio of 1.05. This is a normal value and indicates that CPAY is financially healthy and should not expect problems in meeting its short term obligations.
CPAY's Quick ratio of 1.05 is in line compared to the rest of the industry. CPAY outperforms 51.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05

6

3. Growth

3.1 Past

CPAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.50%, which is quite good.
CPAY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.95% yearly.
CPAY shows a small growth in Revenue. In the last year, the Revenue has grown by 4.68%.
The Revenue has been growing by 9.08% on average over the past years. This is quite good.
EPS 1Y (TTM)9.5%
EPS 3Y15.12%
EPS 5Y9.95%
EPS Q2Q%11.36%
Revenue 1Y (TTM)4.68%
Revenue growth 3Y16.3%
Revenue growth 5Y9.08%
Sales Q2Q%6.01%

3.2 Future

The Earnings Per Share is expected to grow by 15.72% on average over the next years. This is quite good.
CPAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.36% yearly.
EPS Next Y14.35%
EPS Next 2Y15.42%
EPS Next 3Y16.13%
EPS Next 5Y15.72%
Revenue Next Year5.28%
Revenue Next 2Y8.34%
Revenue Next 3Y8.84%
Revenue Next 5Y8.36%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.76, CPAY is valued on the expensive side.
CPAY's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CPAY to the average of the S&P500 Index (28.96), we can say CPAY is valued slightly cheaper.
With a Price/Forward Earnings ratio of 16.66, CPAY is valued correctly.
The rest of the industry has a similar Price/Forward Earnings ratio as CPAY.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, CPAY is valued a bit cheaper.
Industry RankSector Rank
PE 20.76
Fwd PE 16.66

4.2 Price Multiples

CPAY's Enterprise Value to EBITDA ratio is in line with the industry average.
CPAY's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CPAY is cheaper than 77.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.23
EV/EBITDA 14.9

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CPAY has a very decent profitability rating, which may justify a higher PE ratio.
CPAY's earnings are expected to grow with 16.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.45
PEG (5Y)2.09
EPS Next 2Y15.42%
EPS Next 3Y16.13%

0

5. Dividend

5.1 Amount

No dividends for CPAY!.
Industry RankSector Rank
Dividend Yield N/A

CORPAY INC

NYSE:CPAY (11/21/2024, 8:20:43 PM)

After market: 375.46 0 (0%)

375.46

+6.22 (+1.68%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap26.07B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.76
Fwd PE 16.66
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.45
PEG (5Y)2.09
Profitability
Industry RankSector Rank
ROA 5.75%
ROE 32.83%
ROCE
ROIC
ROICexc
ROICexgc
OM 44.43%
PM (TTM) 26.14%
GM 78.29%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 2.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)9.5%
EPS 3Y15.12%
EPS 5Y
EPS Q2Q%
EPS Next Y14.35%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.68%
Revenue growth 3Y16.3%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y